Jay S. Stout's most recent trade in Immunovant Inc was a trade of 1,906 Common Stock done at an average price of $39.5 . Disclosure was reported to the exchange on July 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 08 Jul 2026 | 1,906 | 209,779 (0%) | 0% | 39.5 | 75,344 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 39.53 per share. | 08 Jul 2026 | 1,399 | 208,275 (0%) | 0% | 39.5 | 55,302 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 39.99 per share. | 08 Jul 2026 | 105 | 209,674 (0%) | 0% | 40.0 | 4,199 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 39.99 per share. | 08 Jul 2026 | 77 | 208,198 (0%) | 0% | 40.0 | 3,079 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 38.18 per share. | 26 Jun 2026 | 33,277 | 218,408 (0%) | 0% | 38.2 | 1,270,516 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 38.94 per share. | 26 Jun 2026 | 6,723 | 211,685 (0%) | 0% | 38.9 | 261,794 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 29.62 per share. | 23 Apr 2026 | 2,754 | 251,685 (0%) | 0% | 29.6 | 81,573 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 08 Apr 2026 | 8,614 | 255,957 (0%) | 0% | 24.8 | 213,886 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.83 per share. | 08 Apr 2026 | 1,518 | 254,439 (0%) | 0% | 24.8 | 37,692 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 96,851 | 96,851 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Apr 2026 | 66,937 | 264,571 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 26.03 per share. | 21 Jan 2026 | 1,977 | 197,634 (0%) | 0% | 26.0 | 51,461 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 26.51 per share. | 07 Jan 2026 | 1,148 | 199,666 (0%) | 0% | 26.5 | 30,433 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 26.93 per share. | 07 Jan 2026 | 55 | 199,611 (0%) | 0% | 26.9 | 1,481 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 22 Oct 2025 | 2,520 | 200,814 (0%) | 0% | 19.0 | 47,956 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 08 Oct 2025 | 1,585 | 203,334 (0%) | 0% | 16.3 | 25,836 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 23 Jul 2025 | 2,805 | 204,919 (0%) | 0% | 18.2 | 50,911 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 09 Jul 2025 | 1,519 | 207,724 (0%) | 0% | 17.2 | 26,188 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 14.79 per share. | 23 Apr 2025 | 1,925 | 209,243 (0%) | 0% | 14.8 | 28,471 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Apr 2025 | 5,004 | 211,168 (0%) | 0% | 13.0 | 65,002 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 107,297 | 107,297 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 76,181 | 216,172 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 22 Jan 2025 | 2,195 | 139,991 (0%) | 0% | 23.6 | 51,780 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 29.53 per share. | 23 Oct 2024 | 2,740 | 142,186 (0%) | 0% | 29.5 | 80,912 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 27.76 per share. | 24 Jul 2024 | 2,813 | 144,926 (0%) | 0% | 27.8 | 78,089 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 28.90 per share. | 24 Apr 2024 | 7,239 | 147,739 (0%) | 0% | 28.9 | 209,207 | Common Stock |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 68,723 | 68,723 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 54,978 | 154,978 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 150,000 | 150,000 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Jay S. Stout | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2023 | 100,000 | 100,000 (0%) | 0% | 0 | Common Stock |